3137 WPI
Pill imprint 3137 WPI has been identified as Nizatidine 150 mg.
Nizatidine is used in the treatment of gerd; stomach ulcer; indigestion; erosive esophagitis; duodenal ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy.
Nizatidine 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Nizatidine Images
- Imprint:
-
3137
WPI - Strength:
- 150 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-3137
| NDC Code | Manufacturer / Repackager |
|---|---|
| 63739-0339 | McKesson Packaging Services |
| 21695-0375 | Rebel Distributors Corp (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Nizatidine resources
- Nizatidine (Wolters Kluwer)
- Nizatidine Solution (Wolters Kluwer)
- nizatidine (Cerner Multum)
- Nizatidine (AHFS DI)
- Nizatidine (FDA)
- Nizatidine Solution (FDA)
- Nizatidine (Wolters Kluwer)
Search Again
